Pharmaceutical Law Group Pc

Pharmaceutical Law Group was founded by Gregory Glover MD JD, a registered patent attorney and non-practicing physician. He is one of the nation’s experts on the complex interaction of food and drug laws and intellectual property, including the patent and non-patent provisions of the Drug Price Competition and Patent Term Restoration Act of 1984 (the “Hatch-Waxman Act”). a patent lawyer and non-practicing physician. We represent pharmaceutical and biotechnology developers, manufacturers, and investors regarding market exclusivity strategies and domestic intellectual property issues. Our clients include- Established manufacturers and distributors - Investors including investment banks, VCs, and other funding sources - Business development executives - IP & regulatory specialty law firms - Emerging product development companies We are expert advisors when FDA regulation and intellectual property converge. Typical engagements and consultations relate to strategic intellectual property issues that drive success in the following areas- Due Diligence and Transaction Advice - Hatch-Waxman and BPCIA - Strategic Product Development - Life Cycle Management Additional Areas We also offer insight into emerging conflicts and opportunities for the pharmaceutical industry including the developing market dynamics between innovator biologic products and biosimilars, the rise of personalized medicine and the role of companion and complementary diagnostics, and the impact of drug pricing disputes on pharmaceutical research and development. How Can We Help? Call Us for a Confidential Discussion Our expert consultation frequently focuses on strategies and insights regarding the complex interaction of FDA regulation, intellectual property, and market dynamics that are essential for success in the pharmaceutical and biotechnology sectors.